ARRANTA BIO
Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.
ARRANTA BIO
Industry:
Biotechnology
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
82 M USD
Technology used in webpage:
U.S. Server Location Microsoft Microsoft Azure Microsoft Azure US East Region Salesforce Microsoft Azure Blob Storage Salesforce Web To Lead
Similar Organizations
apceth Biopharma
apceth Biopharma is a GMP contract development and manufacturing organization.
AtomVie Global Radiopharma
AtomVie Global Radiopharma is a global contract development and manufacturing organization.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
NextVivo
NextVivo is a biotech company developing an immune organoid technology platform.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Zhenge Biotech
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-11-13 | Captozyme | Captozyme acquired by Arranta Bio | N/A |
Investors List
Ampersand Capital Partners
Ampersand Capital Partners investment in Series B - Arranta Bio
Ampersand Capital Partners
Ampersand Capital Partners investment in Venture Round - Arranta Bio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-03-01 | Thymmune Therapeutics | Arranta Bio investment in Seed Round - Thymmune Therapeutics | 7 M USD |
Key Employee Changes
More informations about "Arranta Bio"
Recipharm acquires Arranta Bio, a CDMO leader in advanced …
Feb 18, 2022 About Arranta Bio Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking …See details»
Arranta Bio - Crunchbase Investor Profile & Investments
Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic …See details»
Inceptor Bio Announces Agreement to Acquire …
Oct 27, 2021 Additional information about Inceptor Bio is available at www.inceptor.bio. About Arranta Bio Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners …See details»
Arranta Bio announces $82M in new funding, and a strategic …
Oct 30, 2019 Arranta is proud to be building a business to support the supply needs of these innovators. About Arranta Bio. Founded in 2019, Arranta Bio is a contract development and …See details»
Cytiva to provide Arranta Bio “idea to injection” solutions for ...
Arranta Bio - VentureRadar
" Founded in 2019, Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and …See details»
Arranta Bio - MassBio
Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological …See details»
Arranta Bio - Biotech Careers
Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies …See details»
Arranta Bio - workinbiotech.com
Arranta Bio is a contract development and manufacturing organization that focuses on live biotherapeutic products (LBP). Developing advanced therapies is not trivial and requires much …See details»
Recipharm acquires Arranta Bio, a CDMO leader in advanced …
About Arranta Bio Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and …See details»
Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough
Mar 8, 2021 Arranta Bio, the leading microbiome contract development and manufacturing organization, announced the addition of a 130,000-square-foot facility in Boxborough, …See details»
Arranta Bio Announces First End-to-End Manufacturing for mRNA …
Sep 23, 2021 Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and …See details»
Recipharm acquires Arranta Bio, a CDMO leader in advanced …
Feb 18, 2022 In addition, Arranta Bio is progressing the supply of end-to-end mRNA capabilities across drug substance and drug product under one roof, providing its customers with …See details»
Arranta Bio announces the acquisition of Captozyme ... - BioSpace
Nov 13, 2019 Arranta is proud to be the leading CDMO supporting the supply needs of these innovators. About Arranta Bio Founded in 2019, Arranta Bio is a contract development and …See details»
Arranta Bio Company Profile - Office Locations, Competitors
Arranta Bio is a contract development and manufacturing organization (CDMO) established to focus on serving companies seeking to develop and commercialize therapies targeting the …See details»
Arranta Bio Holdings, LLC Company Profile | Gainesville, FL ...
Find company research, competitor information, contact details & financial data for Arranta Bio Holdings, LLC of Gainesville, FL. Get the latest business insights from Dun & Bradstreet.See details»
Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced …
Feb 22, 2017 Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and …See details»
Project Profile: Arranta Bio Manufacturing Facility
Jun 5, 2023 The first phase of Arranta Bio’s new manufacturing facility for microbiome therapeutics has been completed, with the multi-phase project expected to be mechanically …See details»
Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough, …
WATERTOWN, Mass., March 8, 2021 /PRNewswire/ — Arranta Bio (“Arranta”), the leading microbiome contract development and manufacturing organization (CDMO), today announced …See details»
WuXi Biologics Named to CDP Water Security "A List" for Second ...
2 days ago WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been …See details»